154 related articles for article (PubMed ID: 33223734)
21. Serum level of IL-4 predicts response to topical immunotherapy with diphenylcyclopropenone in alopecia areata.
Gong Y; Zhao Y; Zhang X; Qi S; Li S; Ye Y; Yang J; Caulloo S; McElwee KJ; Zhang X
Exp Dermatol; 2020 Mar; 29(3):231-238. PubMed ID: 30047620
[TBL] [Abstract][Full Text] [Related]
22. Limited efficacy of diphenylcyclopropenone in the treatment of alopecia areata: Experience from a Tertiary Healthcare Institution in Singapore.
Leong WMS; Mok ZR; Chandran NS
Dermatol Ther; 2020 Nov; 33(6):e14447. PubMed ID: 33098604
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of QR678 and QR678 Neo
Shome D; Kapoor R; Doshi K; Patel G; Vadera S; Kumar V
J Cosmet Dermatol; 2022 Jan; 21(1):358-367. PubMed ID: 34825770
[TBL] [Abstract][Full Text] [Related]
24. Clinico-Dermoscopic Features and Treatment Responsiveness in Pediatric Alopecia - Experience from a Tertiary Care Pediatric Dermatology Clinic.
Mahajan R; Daroach M; De D; Handa S
Indian J Dermatol; 2020; 65(6):483-488. PubMed ID: 33487703
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
[TBL] [Abstract][Full Text] [Related]
26. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
Lee S; Kim BJ; Lee YB; Lee WS
JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
[TBL] [Abstract][Full Text] [Related]
27. Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin.
Ibrahim SA; Esawy AM; Abdelshafy AS
Dermatol Ther; 2019 Sep; 32(5):e13010. PubMed ID: 31237076
[TBL] [Abstract][Full Text] [Related]
28. A retrospective comparative study of the efficacy and safety of two regimens of diphenylcyclopropenone in the treatment of recalcitrant alopecia areata.
Sriphojanart T; Khunkhet S; Suchonwanit P
Dermatol Reports; 2017 Oct; 9(2):7399. PubMed ID: 29299216
[TBL] [Abstract][Full Text] [Related]
29. Non-scarring patchy alopecia in patients with systemic lupus erythematosus differs from that of alopecia areata.
Ye Y; Zhao Y; Gong Y; Zhang X; Caulloo S; Zhang B; Cai Z; Yang J; McElwee KJ; Zhang X
Lupus; 2013 Dec; 22(14):1439-45. PubMed ID: 24132518
[TBL] [Abstract][Full Text] [Related]
30. Hair repigmentation and regrowth in a dupilumab-treated paediatric patient with alopecia areata and atopic dermatitis: a case report.
Yan X; Tayier M; Cheang ST; Liao Z; Dong Y; Yang Y; Ye Y; Zhang X
Ther Adv Chronic Dis; 2023; 14():20406223231191049. PubMed ID: 37546700
[TBL] [Abstract][Full Text] [Related]
31. A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata.
Al Bazzal A; Hatami P; Abedini R; Etesami I; Ayanian Z; Ghandi N
Int Immunopharmacol; 2021 Dec; 101(Pt B):108186. PubMed ID: 34710658
[TBL] [Abstract][Full Text] [Related]
32. Trichoscopy as an evaluation method for alopecia areata treatment: A comparative study.
Fawzy MM; Abdel Hay R; Mohammed FN; Sayed KS; Ghanem MED; Ezzat M
J Cosmet Dermatol; 2021 Jun; 20(6):1827-1836. PubMed ID: 32991045
[TBL] [Abstract][Full Text] [Related]
33. Dermoscopic clues to distinguish trichotillomania from patchy alopecia areata.
Abraham LS; Torres FN; Azulay-Abulafia L
An Bras Dermatol; 2010; 85(5):723-6. PubMed ID: 21152803
[TBL] [Abstract][Full Text] [Related]
34. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation.
El Taieb MA; Ibrahim H; Nada EA; Seif Al-Din M
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27791311
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic outcome of diphencyprone and its correlation with serum cytokine profile in alopecia areata.
Manimaran RP; Ramassamy S; Rajappa M; Chandrashekar L
J Dermatolog Treat; 2022 Feb; 33(1):324-328. PubMed ID: 32249656
[TBL] [Abstract][Full Text] [Related]
36. Imiquimod-enhanced immunotherapy with diphencyprone for patients with alopecia areata.
Díaz-Guimaraens B; Saceda-Corralo D; Hermosa-Gelbard Á; Moreno-Arrones ÓM; Dominguez-Santas M; Suarez-Valle A; Vañó-Galván S
Dermatol Ther; 2022 Jul; 35(7):e15516. PubMed ID: 35421278
[TBL] [Abstract][Full Text] [Related]
37. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
Galadari I; Rubaie S; Alkaabi J; Galadari H
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
[TBL] [Abstract][Full Text] [Related]
38. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
[TBL] [Abstract][Full Text] [Related]
39. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
Aghaei S
BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
[TBL] [Abstract][Full Text] [Related]
40. Comparative study for treatment of alopecia areata using carboxy therapy, intralesional corticosteroids, and a combination of both.
Metwally D; Abdel-Fattah R; Hilal RF
Arch Dermatol Res; 2022 Mar; 314(2):167-182. PubMed ID: 33742252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
